Logo image of AXTI

AXT INC (AXTI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AXTI - US00246W1036 - Common Stock

15.37 USD
+0.36 (+2.4%)
Last: 12/26/2025, 8:00:00 PM
15.85 USD
+0.48 (+3.12%)
Pre-Market: 12/29/2025, 4:40:53 AM
Fundamental Rating

2

Taking everything into account, AXTI scores 2 out of 10 in our fundamental rating. AXTI was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. AXTI may be in some trouble as it scores bad on both profitability and health. AXTI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AXTI has reported negative net income.
AXTI had a negative operating cash flow in the past year.
In multiple years AXTI reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: AXTI reported negative operating cash flow in multiple years.
AXTI Yearly Net Income VS EBIT VS OCF VS FCFAXTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.88%, AXTI is doing worse than 70.80% of the companies in the same industry.
AXTI's Return On Equity of -12.83% is on the low side compared to the rest of the industry. AXTI is outperformed by 71.68% of its industry peers.
Industry RankSector Rank
ROA -6.88%
ROE -12.83%
ROIC N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
AXTI Yearly ROA, ROE, ROICAXTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

AXTI's Gross Margin of 11.97% is on the low side compared to the rest of the industry. AXTI is outperformed by 84.96% of its industry peers.
AXTI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AXTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
AXTI Yearly Profit, Operating, Gross MarginsAXTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

2

2. Health

2.1 Basic Checks

AXTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
AXTI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AXTI has more shares outstanding
AXTI has a worse debt/assets ratio than last year.
AXTI Yearly Shares OutstandingAXTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXTI Yearly Total Debt VS Total AssetsAXTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.78 indicates that AXTI is not a great score, but indicates only limited risk for bankruptcy at the moment.
AXTI's Altman-Z score of 2.78 is in line compared to the rest of the industry. AXTI outperforms 43.36% of its industry peers.
AXTI has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.35, AXTI is not doing good in the industry: 64.60% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 2.78
ROIC/WACCN/A
WACC10.55%
AXTI Yearly LT Debt VS Equity VS FCFAXTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

AXTI has a Current Ratio of 1.76. This is a normal value and indicates that AXTI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of AXTI (1.76) is worse than 78.76% of its industry peers.
A Quick Ratio of 0.85 indicates that AXTI may have some problems paying its short term obligations.
The Quick ratio of AXTI (0.85) is worse than 90.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 0.85
AXTI Yearly Current Assets VS Current LiabilitesAXTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

4

3. Growth

3.1 Past

The earnings per share for AXTI have decreased strongly by -113.04% in the last year.
Looking at the last year, AXTI shows a decrease in Revenue. The Revenue has decreased by -4.54% in the last year.
AXTI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.59% yearly.
EPS 1Y (TTM)-113.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)-4.54%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%18.23%

3.2 Future

AXTI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.77% yearly.
The Revenue is expected to grow by 15.92% on average over the next years. This is quite good.
EPS Next Y-75.69%
EPS Next 2Y42.02%
EPS Next 3Y53.77%
EPS Next 5YN/A
Revenue Next Year-4.14%
Revenue Next 2Y12.59%
Revenue Next 3Y15.92%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AXTI Yearly Revenue VS EstimatesAXTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
AXTI Yearly EPS VS EstimatesAXTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

AXTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 3767.16, which means the current valuation is very expensive for AXTI.
Based on the Price/Forward Earnings ratio, AXTI is valued a bit more expensive than 66.37% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AXTI to the average of the S&P500 Index (23.46), we can say AXTI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 3767.16
AXTI Price Earnings VS Forward Price EarningsAXTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 1K 2K 3K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AXTI Per share dataAXTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

AXTI's earnings are expected to grow with 53.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.02%
EPS Next 3Y53.77%

0

5. Dividend

5.1 Amount

AXTI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AXT INC

NASDAQ:AXTI (12/26/2025, 8:00:00 PM)

Premarket: 15.85 +0.48 (+3.12%)

15.37

+0.36 (+2.4%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-18 2026-02-18/amc
Inst Owners34.96%
Inst Owner Change2.41%
Ins Owners1.85%
Ins Owner Change-2.06%
Market Cap716.55M
Revenue(TTM)90.39M
Net Income(TTM)-22.98M
Analysts83.64
Price Target9.69 (-36.96%)
Short Float %4.65%
Short Ratio0.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.25%
Min EPS beat(2)-14.71%
Max EPS beat(2)75.2%
EPS beat(4)1
Avg EPS beat(4)-28.28%
Min EPS beat(4)-130.68%
Max EPS beat(4)75.2%
EPS beat(8)5
Avg EPS beat(8)2.35%
EPS beat(12)8
Avg EPS beat(12)7.78%
EPS beat(16)12
Avg EPS beat(16)13.48%
Revenue beat(2)1
Avg Revenue beat(2)12.04%
Min Revenue beat(2)-10.9%
Max Revenue beat(2)34.98%
Revenue beat(4)2
Avg Revenue beat(4)6.72%
Min Revenue beat(4)-10.9%
Max Revenue beat(4)34.98%
Revenue beat(8)5
Avg Revenue beat(8)4.66%
Revenue beat(12)5
Avg Revenue beat(12)0.71%
Revenue beat(16)6
Avg Revenue beat(16)0.36%
PT rev (1m)0%
PT rev (3m)148.69%
EPS NQ rev (1m)66.15%
EPS NQ rev (3m)80.99%
EPS NY rev (1m)18.85%
EPS NY rev (3m)25.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)31%
Revenue NY rev (1m)0%
Revenue NY rev (3m)18.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3767.16
P/S 7.93
P/FCF N/A
P/OCF N/A
P/B 4
P/tB 4
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)0
Fwd EY0.03%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.94
BVpS3.84
TBVpS3.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.88%
ROE -12.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.97%
FCFM N/A
ROA(3y)-1.43%
ROA(5y)0.21%
ROE(3y)-2.64%
ROE(5y)0.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.41%
GM growth 5Y-4.23%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.67%
Cap/Sales 3.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 0.85
Altman-Z 2.78
F-Score3
WACC10.55%
ROIC/WACCN/A
Cap/Depr(3y)178.33%
Cap/Depr(5y)282.49%
Cap/Sales(3y)13.27%
Cap/Sales(5y)16.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y-75.69%
EPS Next 2Y42.02%
EPS Next 3Y53.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.54%
Revenue growth 3Y-10.24%
Revenue growth 5Y3.59%
Sales Q2Q%18.23%
Revenue Next Year-4.14%
Revenue Next 2Y12.59%
Revenue Next 3Y15.92%
Revenue Next 5YN/A
EBIT growth 1Y-99.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-731.84%
OCF growth 3YN/A
OCF growth 5YN/A

AXT INC / AXTI FAQ

What is the fundamental rating for AXTI stock?

ChartMill assigns a fundamental rating of 2 / 10 to AXTI.


What is the valuation status of AXT INC (AXTI) stock?

ChartMill assigns a valuation rating of 1 / 10 to AXT INC (AXTI). This can be considered as Overvalued.


Can you provide the profitability details for AXT INC?

AXT INC (AXTI) has a profitability rating of 1 / 10.


What is the financial health of AXT INC (AXTI) stock?

The financial health rating of AXT INC (AXTI) is 2 / 10.